leisure time -WSS

leisure time

author：hotspot 2025-10-01 23:58:54 - browse：83

insulin biosimilar — Last week, the FDA released a trio of guidelines clarifying the way they plan to evaluate devices that go through the 510(k) pathway. Jacquelyn Martin/AP

Five years after promising to fix a flawed regulatory pathway widely used by medical device manufacturers, the Food and Drug Administration has issued new guidelines to improve its so-called 510(k) program that has long been lambasted for letting risky devices fall through the cracks.

Most medical device companies do not have to test their products on people in order to secure clearance from the FDA — they simply have to show they’re “substantially equivalent” to devices already on the market, called “predicates.” This process is the 510(k) pathway, and accounts for the vast majority of new medical devices launched on the market each year. Devices cleared through this pathway include X-ray machines, muscle stimulators, and wheelchairs.

Last week, the FDA released a trio of guidelines clarifying the way it plans to evaluate devices that go through the 510(k) pathway. The agency is asking manufacturers to avoid predicate devices that were recalled due to a “design-related” issue or have “unmitigated” safety concerns. Manufacturers should submit flow charts explaining why they chose their predicate device. If they have to choose one with a recall history or safety issues, they should explain how the new device addresses those problems. The FDA may also ask the manufacturer for clinical data in this case.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： More regulation could be coming for drug ads

WSS

Report: NIH

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

FTX founder Sam Bankman

Sage's campaign to raise awareness of postpartum depression hits a nerve

Average age of first period drops to 11.9 years, study shows

Mega Millions jackpot estimated at record $1.58 billion for Tuesday's drawing

focus

leisure time

hotspot

Bright Health sells Medicare Advantage business to Molina

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Focused ultrasound for uterine fibroids: an uphill battle

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Travel bans should be based on evidence, not politics or fear

Malaria cases in Florida and Texas: Here’s what you need to know

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

Alkermes shareholders re

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

entertainment

Travel bans should be based on evidence, not politics or fear

Report: NIH

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

Lab trade group sues FDA to halt regulation of lab

Scientists successfully use ultrasound imaging to map brain activity

More regulation could be coming for drug ads

entertainment

explore

focus

leisure time